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Abstract
Background: Bone marrow lesions (BMLs) are useful diagnostic and prognostic markers in knee osteoarthritis (OA),
but what they represent at the tissue level remains unclear. The aim of this study was to provide comprehensive tissue
characterization of BMLs detected using two specific MRI sequences.
Methods: Tibial plateaus were obtained from 60 patients (29 females, 31 males), undergoing knee arthroplasty for OA.
To identify BMLs, MRI was performed ex vivo using T1 and PDFS-weighted sequences. Multi-modal tissue level analyses
of the osteochondral unit (OCU) were performed, including cartilage volume measurement, OARSI grading, micro-CT
analysis of bone microstructure, routine histopathological assessment and quantitation of bone turnover indices.
Results: BMLs were detected in 74 % of tibial plateaus, the remainder comprising a No BML group. Of all BMLs, 59 %
were designated BML 1 (detected only by PDFS) and 41 % were designated BML 2 (detected by both PDFS + T1). The
presence of a BML was related to degeneration of the OCU, particularly within BML 2. When compared to No BML,
BML 2 showed reduced cartilage volume (p = 0.008), higher OARSI scores (p = 0.004), thicker subchondral plate
(p = 0.002), increased trabecular bone volume and plate-like structure (p = 0.0004), increased osteoid volume
(p = 0.002) and thickness (p = 0.003), more bone marrow oedema (p = 0.03), fibrosis (p = 0.002), necrosis (p = 0.01)
and fibrovascular cysts (p = 0.04). For most measures, BML 1 was intermediate between No BML and BML 2.
Conclusions: BMLs detected by specific MRI sequences identify different degrees of degeneration in the OCU.
This suggests that MRI characteristics of BMLs may enable identification of different BML phenotypes and help
target novel approaches to treatment and prevention of OA.
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Background
Knee osteoarthritis (OA), a painful degenerative condi-
tion with no effective treatment, is one of the leading
causes of human suffering. It is widely accepted that OA
is a disease of the whole joint, with particular involve-
ment of the articular cartilage and subchondral bone. In
fact, these two tissues act as a functional unit, the
osteochondral unit (OCU), to maintain joint homeosta-
sis [1]. Pathological changes in either the bone or the
cartilage seem to predict degenerative changes in the
other.
Focal changes in the subchondral bone, termed bone
marrow lesions (BMLs), are features detected by mag-
netic resonance imaging (MRI) that have been reported
to be closely associated with the severity of symptoms of
OA such as pain [2–4] and OCU degeneration (e.g., loss
of the overlying cartilage) [5–8]. Clinical studies have re-
ported BMLs in both patients with early asymptomatic
OA [9–12] and in those with severe late-stage OA [6,
* Correspondence: dzenita.muratovic@adelaide.edu.au
1Discipline of Orthopaedics and Trauma, The University of Adelaide, Adelaide,
Australia
2Bone and Joint Research Laboratory, SA Pathology, Frome Road, Adelaide
5000, Australia
Full list of author information is available at the end of the article
© 2016 Muratovic et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Muratovic et al. Arthritis Research & Therapy  (2016) 18:54 
DOI 10.1186/s13075-016-0953-x
13–15]. In patients with early OA and in individuals
who do not have OA, BMLs can decrease in size or re-
solve completely [2, 5, 16]. Hunter et al. reported that in
progressive OA, BMLs are more likely to persist and to
enlarge in size [6]. Previous human histological studies
examined small numbers of samples and found mixed
pathological findings of bone marrow and sclerotic bone
in BMLs [17–19]. Similar histopathological findings have
been reported for animal models of OA [20].
BMLs are conventionally assessed using fat-suppressed
or proton-dense T2-weighted MRI, although they may
also be detected using other MRI sequences. Within fat-
suppressed T2-weighted and/or proton density-weighted
sequences they appear as areas of ill-defined hyperinten-
sity (high signal) in subchondral bone, and in T1-weighted
sequences they appear hypointense (low signal) [21–25].
Thus, although fat-suppressed T2-weighted and/or proton
density-weighted sequences are recommended for the as-
sessment of BMLs as they depict lesions to their max-
imum extent, T1-weighted sequences are predominantly
used for assessment of the cartilage. Preferably, a combin-
ation of sequences should be used to evaluate the extent
of OA disease progression [5, 14, 26, 27].
There is extensive debate about the optimal way to
image BMLs but it remains unknown whether BMLs de-
tected by different MRI sequences differ at the tissue
level. Thus, it is possible that amongst BMLs identified
by conventional T2-weighted images, some may also be
detectable using another MRI sequence, but others may
not. This would suggest that the underlying tissues in
these groups are not the same and may thus relate to
different clinical outcomes. As BMLs are closely associ-
ated with pain and loss of cartilage [12, 14, 28, 29], they
are emerging as promising targets for monitoring pro-
gression of knee OA [30] and the effects of treatment
[31]. Therefore, a comprehensive understanding of the
underlying pathology of BMLs is important.
The aim of this study was to comprehensively investi-
gate histological changes in all components of the OCU
(cartilage, subchondral bone and subchondral bone mar-
row) based on the presence or absence of a BML de-
tected by two specific MRI sequences, in tibial plateau
tissue obtained during knee replacement surgery.
Methods
Patient samples
Tibial plateaus (TP) were obtained from 60 patients
undergoing knee arthroplasty surgery (29 female patients
aged 51 to 87 years, body mass index (BMI) range 24.1–
41.4 and 31 male patients aged 42 to 86 years, BMI
range 22.6–45.7). Written consent was obtained from all
patients and the study received prior approval from the
Human Research Ethics Committee at the Repatriation
General Hospital, Royal Adelaide Hospital and The
University of Adelaide, South Australia, in accordance
with the Declaration of Helsinki 1975.
Inclusion criteria were: radiographic evidence of OA
with severe symptomatic disabilities, such as severe pain
and limited mobility. Exclusion criteria were secondary
OA of the knee due to trauma or rheumatoid arthritis,
evidence of bone-related chronic debilitating disease
and/or history of any medication that may have affected
bone turnover.
Macroscopic evaluation
All retrieved TP were examined and graded macroscop-
ically according to the Outerbridge Classification [26,
32] by two experienced orthopedic surgeons (DM and
CW), for whom the intraclass correlation coefficient
(ICC) for inter-observer reproducibility was 0.81 (95 %
CI 0.79, 0.84).
Radiographic evaluation of knee OA
Standing anteroposterior, posteroanterior and lateral
projection radiographs were taken prior to surgery. The
extent of radiographic evidence of progression of OA
was assessed according to the Kellgren and Lawrence
(K&L) grade, the current standard radiologic grading
system for OA. All radiographs were scored by two ex-
perienced assessors (AW and YW) with 5 % disagree-
ment. Assessors were blinded to the presence of BMLs
in the knee joint.
Magnetic resonance imaging
Specimens were scanned ex vivo using an MRI scanner
with an 8-channel wrist coil (3 T MRI Siemens TRIO,
Berlin, Germany), with two specific sequences: fat-
suppressed (FS) fast spin-echo proton density-weighted
(PDFS) and T1-weighted spin echo in the sagittal and cor-
onal planes. Sagittal slice thickness was 1.6 mm with a dis-
tance factor of 25 %; coronal slice thickness was 3.0 mm
with a 10 % distance factor. We confirmed that ex vivo
MRI information corresponded to pre-operative imaging,
by comparing pre- and post-operative MRI data for a sub-
set of five patients, consistent with previous reports [20,
33, 34].
The definition for identification of BMLs was by mu-
tual agreement between two radiologists with musculo-
skeletal MRI expertise (DT and YW). A BML is defined
as a zone of altered signal intensity in the bone and mar-
row, located immediately beneath the articular cartilage
and visible on at least two consecutive slices [7, 13, 35].
Based on the presence and/or absence of signal, two
subtypes of BML were defined. BMLs detected using the
PDFS sequence only and with absent signal on T1-
weighted sequence in the same area are referred to as
BML 1; BMLs detected by both PDFS and T1 sequences
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are referred to as BML 2. (Fig. 1 shows examples of
BML 1 and BML 2).
After identification of a BML the external contours of
the BMLs were marked in both planes by two re-
searchers (DzM and YRL) blinded to the presence of
BMLs. The volume and precise location of each BML
was determined, enabling the creation of a two-
dimensional (2D) axial map of all BMLs (Fig. 2 demon-
strates the approximate size and location of both BMLs).
Cartilage volume in the medial compartment was deter-
mined as described previously [7, 25]. The coefficient of
variation for the measurement of cartilage volume at the
medial tibia was 2.2 %.
Micro-computed tomography (micro-CT)
A subset of 36 TP (6 mm minimal thickness) was
scanned by micro-CT (Skyscan model 1076, Kontic,
Belgium). Images were obtained at isotropic resolution
of 17.4 μm. Using AVIZO® Fire software (Zuse Institute,
Berlin, Germany), and three-dimensional (3D) volumes
of TP were generated using both MRI and micro-CT
images. Then, the BML signal location was identified
from MRI and aligned onto the 3D volume of micro-
CT. A cylindrical region of interest (ROI) containing the
volume of the BML, diameter 10 mm × depth 6 mm, was
used for analysis of BML bone microstructure. As BMLs
were found predominantly on the medial side, the same
size and shape ROI was used in the medial compartment
of the TP without BMLs. These ROIs were further di-
vided into the subchondral plate and subchondral
trabecular bone regions and analyzed separately, using
CT-An analyzer software (SkyScan).
Microscopic evaluation
A cuboidal block of cartilage-subchondral bone (10 ×
10 × 5 mm), representing the area containing a BML
Fig. 1 Left, upper and lower panels show tibial plateaus in the transaxial plane. Right, green line is the sagittal slice. Upper panel, middle, the signal
of the bone marrow lesion (BML) is detected by fast spin-echo proton density-weighted (PDFS) sequence (arrows identify signal), and right the
signal is not detected by T1-weighted sequence. Lower panel, middle, the signal of the BML is detected by PDFS sequence (arrows identify signal),
and right the signal is detected by T1-weighted sequence
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(named BML), was dissected from the TP using a low-
speed diamond saw (Model 660, South Bay Technology,
San Clemente, US). A tissue block of the same size and
shape was cut from the medial compartment of the TP
without BMLs (no BML). Each cube was divided equally,
with one half formalin-fixed, processed and embedded
in methyl-methacrylate resin. The block was cut into 5-
μm-thick sections and stained with von Kossa silver/
hematoxylin and eosin (H&E) for histomorphometric
analysis of bone remodeling. The other half of the block
was formalin-fixed, decalcified in 5 % hydrochloric acid,
paraffin-embedded, sectioned 5-μm-thick and stained
with H&E and Safranin-O/Fast Green. A senior patholo-
gist (SO) with over 10 years of experience in the field,
blinded to the MRI findings, used a 1–5 scoring system
to semiquantitatively evaluate the presence and extent
of pathological findings in the tissue on the H&E slides,
where 1 = <5 % (minimal presence), 2 = 5–14 %, 3 = 15–
25 % (moderate presence), 4 = 25–50 % and 5 = >50 %
(prominent presence). The intra-observer reproducibil-
ity of the histological scores (assessed by SO) was mea-
sured at separate times for ten sections (ICC 0.98 (95 %
CI 0.95, 0.98)). Safranin-O/Fast Green was used for
Osteoarthritis Research Society International (OARSI)
grading [36, 37]. Consensus between three assessors
(DzM, EG and YRL) determined the grading. The ICC
for inter-observer reproducibility was 0.82 (95 % CI
0.80, 0.84).
Statistical analysis
The Shapiro–Wilk test was used to determine normality
of the data distribution. Differences between the no
BML and the BML (BML 1 + BML 2) groups were de-
scribed using the unpaired t test for parametric distribu-
tion or the Mann–Whitney U test for non-parametric
data distribution. Differences between three groups (no
BML (no BML detected), BML 1 (BML detected only by
PDFS sequence) and BML 2 (BML detected by both
PDFS and T1 sequences)) were described using analysis
of variance (ANOVA). For parametric data, ANOVA and
the Holm–Sidak comparison test with single pooled
variance were performed. For non-parametric data, the
Kruskal–Wallis test and Dunn’s multiple comparison
test were performed. An adjusted model was then per-
formed for all outcome parameters versus BML group,
adjusting for age, sex and BMI. P values <0.05 were con-
sidered to be statistically significant.
Results
Demographic characteristics of the participating indi-
viduals were grouped according to the presence or
absence of BML on specific MRI sequences, and are
Fig. 2 The approximate external contour of each bone marrow lesion (BML) area was marked. The precise map location was placed by identifying the
number of sagittal and coronal slices with measurement of distance from the external tibial contour. After marking the position of the BML for all
specimens, a distribution map of both types of BML was found. BML 1 bone marrow lesion detected using the fast spin-echo proton density-weighted
sequence only, with absent signal on T1-weighted sequence in the same area, BML 2 bone marrow lesions detected by both fast spin-echo proton
density-weighted and T1 sequences
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summarized in Table 1. There were no significant dif-
ferences between the two groups in patient age, gen-
der, BMI or K&L grade.
BMLs were detected in 44 (73 %) of TP; 12 (20 %) of
TP were without BML and/or subchondral cysts (the no
BML group). Of the TP with a BML, 12 (27 %) also had
a subchondral cyst present in the intercondylar space.
Furthermore, 4 TP (6 % of all subjects) had cysts but
without BML and therefore were excluded from further
analysis. BMLs detected using the PDFS sequence only
(BML 1) represented 59 % of all BMLs. The signal inten-
sity in these lesions was either moderate or diffuse in the
PDFS sequence and by definition there was no signal on
the T1-weighted sequence in the same areas. BMLs de-
tected by both PDFS and T1 sequences (BML 2) repre-
sented 41 % of all BMLs. The signal intensity in BML 2
was hyperintense on the PDFS sequence and hypoin-
tense on the T1-weighted sequence. Preoperative radio-
graphs indicated that 77 % of TP with BML were
diagnosed with medial OA, 14 % with lateral OA and
9 % with patellofemoral OA (Table 1). Furthermore,
both BML types were present predominantly in the
medial compartment of TP (87 %), with their anatomical
distribution aligning closely with the menisci (Fig. 2).
Firstly, we examined whether structural changes in all
components of the OCU (cartilage, subchondral bone
and subchondral bone marrow) differed based on the
presence or absence of a BML detected by two specific
MRI sequences. In TP with BML, areas corresponding
to a BML, either BML 1 or BML 2, were compared to
anatomically matched areas in TP without BML, and
progressive degenerative changes were found in BML
areas for all tested parameters. These included a higher
Outerbridge score, reduced cartilage volume, higher
OARSI score (Table 1), more histopathological abnor-
malities such as tidemark duplication, penetration of
vascular cones into calcified cartilage, edema, necrosis,
fibrosis, the presence of thick-walled arterioles, and
small fibrovascular cystic formations (Table 2). BML
containing subchondral bone had thicker subchondral
plate, increased trabecular bone volume, more trabecu-
lae that were predominantly plate-like, increased osteoid
volume and thickness of both plate and trabeculae and
decreased eroded surface in trabecular bone (Table 3).
We then examined whether the extent of these
changes was different depending on the BML subtype.
BMLs detected by both PDFS and T1 sequences (BML
2) were identified as lesions having the most advanced
degenerative changes throughout the whole OCU. In
fact, they displayed all the changes described above for
subchondral bone with BML signal (Figs. 3 and 4). In
contrast, BMLs detected only by the PDFS sequence
(BML 1) displayed a subset of the intermediate degen-
erative changes when compared to TP with no BML and
those with BML 2 (Figs. 3 and 4).
To assess whether the histological composition of
BML visualized by different sequences differed, we
compared BML 1 and BML 2. The BML 2 were asso-
ciated with reduced cartilage volume (p = 0.007) more
fibrosis (p = 0.006) and necrosis (p = 0.01) in the bone
marrow (Fig. 3), thicker subchondral bone plate (p =
0.002), with higher osteoid thickness (O.Th) (p = 0.04)
in trabecular bone and with no differences between
histomorphometric parameters besides higher osteoid
volume/bone volume (OV/BV) (p = 0.02) compared to
BML 1 (Fig. 4).
Table 1 Patient demographic characteristics
No BML (n = 12) Total BML (1 + 2) (n = 44) P value
Agea 69.8 ± 1.4 68.3 ± 1.2 0.5
Male, number (%) 3 (25 %) 25 (57 %) 0.06
Female, number (%) 9 (75 %) 19 (43 %) 0.1
BMIa 31.3 ± 6.4 33.4 ± 5.1 0.2
K&L gradeb 2 (1, 4) 3 (2, 4) 0.7
Medial OA, number of patients (%) 6 (50 %) 34 (77 %) 0.07
Lateral OA, number of patients (%) 2 (16 %) 6 (14 %) 0.5
Patello-femoral OA, number of patients (%) 4 (33 %) 4 (9 %) 0.04
Subchondral cyst present, number of patients (%) 0 (0 %) 12 (27 %) 0.03
Outerbridge classificationb 3 (3, 4) 4 (3, 4) 0.04
Cartilage volumea 1.3 ± 0.2 0.9 ± 0.3 0.01
OARSI scorea 3.7 ± 1.2 5 ± 0.9 0.004
aValues presented with mean ± standard deviation. bValues presented with median (25th, 75th percentiles). P values are for difference between the group with no
bone marrow lesions (No BML) and the group with BML (BML 1 + BML 2). BMI body mass index, K&L Kellgren and Lawrence, OA osteoarthritis, OARSI Osteoarthritis
Research Society International
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Discussion
In this study we found that BMLs detected using different
MRI sequences in OA can differentiate the degree of de-
generation through the OCU. Broadly, two subtypes of
BMLs could were identified by specific MRI sequences,
which corresponded to different tissue features. BML 1,
seen only on the PDFS sequence involved less severe OA
change than BML 2, seen on both PDFS and T1 sequences.
Our study confirmed previous findings of BMLs being
predominantly present in the medial compartment of
the tibial plateau. Importantly, we found that loss of car-
tilage volume and degenerative changes were strongly
influenced by the presence of a specific type of BML.
The tibial cartilage volume was found to decrease pro-
gressively in the knee with no BML, to BML 1 (detected
using the PDFS sequence only), and to be almost com-
pletely lost with BML 2 (BMLs detected by both PDFS
and T1 sequences). The loss of medial tibial cartilage
overlying BMLs is consistent with previous clinical
studies [7, 8, 38] showing that the presence of BMLs in
the medial compartment increases the risk of radio-
graphic evidence of progression of OA (hazard ratio 6.5)
and greater cartilage volume loss, [39]. Our finding of
BML-related loss of cartilage supports the notion that
changes in the subchondral bone are connected to the
progression of OA and that it is of significant import-
ance to increase our understanding of BMLs.
Table 2 Histological findings in the no BML and BML groups
No BML
(n = 12)
BML (1 + 2)
(n = 44)
P value
TM, number/mm2 a 2 (2, 3) 3 (3, 4) <0.0001
Vascular cones, number/mm2 b 0.12 ± 0.07 0.20 ± 0.12 0.004
Edema 0.006
Score 1 (<5 %) 83 % 41 %
Score 2 (5–14 %) 17 % 31.8 %
Score 3 (15–24 %) - 20.4 %
Score 4 (25–50 %) - 6.8 %
Score 5 (>50 %) - -
Fibrosis 0.4
Score 1 (<5 %) 75 % 66 %
Score 2 (5–14 %) 25 % 16 %
Score 3 (15–24 %) - 11 %
Score 4 (25–50 %) - 7 %
Score 5 (>50 %) - -
Necrosis 0.002
Score 1 (<5 %) 33.1 % 9 %
Score 2 (5–14 %) 66.6 % 41 %
Score 3 (15–24 %) - 41 %
Score 4 (25–50 %) - 6.8 %
Score 5 (>50 %) - 2.2 %
Th. wall Art., number/mm2 a 0.07 (0.06, 0.1) 0.2 (0.1, 0.4) <0.0001
Fibrovascular c., number/mm2 a 0 (0 %) 0 (0, 0.2) 0.01
aValues presented with median (25th, 75th percentiles). bValues presented with
mean ± standard deviation. P values are for difference between the group with
no bone marrow lesions (No BML) and the group with BML (BML 1 + BML 2).
TM tidemark duplications, Vascular cones vascular cones penetrating from
subchondral bone into calcified cartilage, Th. wall Art thick-walled arterioles
present in marrow, Fibrovascular c. fibrovascular cystic formations
Table 3 Micro-CT analysis and bone turnover
No BML (n = 12) BML (1 + 2) (n = 44) P value
Micro-CT - subchondral plate
Pl.Th, mma 0.44 ± 0.10 0.95 ± 0.29 0.001
Surface cl.poresb 49.5 (23, 83.7) 103.7 (60, 203) 0.007
Micro-CT - subchondral trabeculae
BV/TV, %a 12.06 ± 3.5 16.7 ± 5.1 0.02
Tb.N, number/mma 0.9 ± 0.2 1.2 ± 0.3 0.04
Tb.Sp, mmb 0.9 (0.9, 1) 1.2 (1, 1.5) 0.06
Tb.Th, mmb 0.13 (0.11, 0.15) 0.14 (0.12, 0.16) 0.2
Tb.Pfa -2.2 ± 3.7 -9.3 ± 7.8 0.02
SMIa 1.32 ± 0.4 0.62 ± 0.8 0.02
DAb 1.5 (1.4, 1.6) 1.6 (1.5, 1.8) 0.5
Bone remodeling - subchondral plate
O.Th, μma 36 ± 8.9 43 ± 10.9 0.03
OS/BS, %b 2.5 (1.1, 3.6) 5.1 (3.6, 7.2) 0.0001
OS/BV, mm2/mm3b 1.9 (0.8, 2.8) 2 (1.5, 3.6) 0.3
OS/TV, mm2/mm3a 0.4 ± 0.2 0.8 ± 0.4 0.004
OV/BV, %b 7.1 (3.4, 8.8) 9.4 (6.1, 15) 0.08
OV/TV, %b 1.6 (0.7, 2.1) 3.5 (2, 5.6 0.001
ES/BS, %b 0.03 (0, 0.1) 0.09 (0.01, 0.17) 0.1
ES/BV, mm2/mm3b 0.02 (0, 0.06) 0.03 (0.007, 0.07) 0.5
ES/TV, mm2/mm3b 0.004 (0, 0.01) 0.01 (0.002, 0.02) 0.1
Bone remodeling - subchondral trabeculae
O.Th, μmb 24.7 (22.4, 32.2) 38.1 (27.6, 46.3) 0.005
OS/BS (%)b 3.4 (1.9, 3.9) 3 (1.4, 5.8) 0.6
OS/BV, mm2/mm3b 1.9 (1.1, 2.9) 2.2 (1.4, 3.5) 0.3
OS/TV, mm2/mm3b 0.4 (0.3, 0.5) 0.7 (0.4, 1.1) 0.04
OV/BV, %b 3.6 (2.3, 5.5) 4.7 (2.0, 7.3) 0.04
OV/TV, %b 1.2 (0.8, 1.7) 2 (1.2, 5.4) 0.008
ES/BS, %b 0.2 (0.1, 0.5) 0.1 (0.09, 0.2) 0.02
ES/BV, mm2/mm3b 0.1 (0.04, 0.1) 0.07 (0.05, 0.1) 0.8
ES/TV, mm2/mm3b 0.02 (0.01, 0.03) 0.02 (0.01, 0.04) 0.7
aValues presented with mean ± standard deviation. bValues presented with
median (25th, 75th percentiles). P values are for difference between the group
with no bone marrow lesions (no BML) and the group with BML (BML 1 + BML
2). cl.pores closed pores, Micro-CT micro computed tomography, BV bone
volume, TV tissue volume, Tb.N trabecular number, Tb.Sp trabecular separation,
SMI structural model index, Tb.Th trabecular thickness, O.Th osteoid thickness,
OS osteoid surface, BS bone surface, ES erosion surface, OV osteoid volume,
Pl.Th Plate thickness, Tb.Pf trabecular patern factor, DA degree of anisotropy
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Our findings of histological differences between BMLs
detected by different MRI sequences are intriguing. The
study by Zanetti et al. was one of the first to describe
the histology of BMLs and in that study it was found
that edema is minimally present, suggesting the term
“bone marrow lesion” is used for these features [17].
Our results showed that BML 2 had significantly greater
edema, fibrosis and necrosis present in bone marrow
compared to the no BML group and BML 1. Other hu-
man and animal histological studies [18–20] confirmed
that BMLs are characterized by mixed pathological ap-
pearances and have not found specific histopathological
changes in BML to explain the MRI signal, although it
was suggested by Saadat et al. that the hyperintense MRI
signal might result from increased blood flow [40]. We
analyzed the density of vascular cones in the subchon-
dral plate and the number of small thick-walled
arterioles in the bone marrow corresponding to the
BML signal in ex vivo samples. We found that the
subchondral plate and the marrow of both BML 1 and
BML 2 contained significantly more vascular cones and
small thick-walled arterioles compared to the no BML
group. Therefore, although there was obviously no blood
flow in the ex vivo samples, it remains possible that the
signals relate somehow to the altered vascular structures
associated with BMLs.
Guymer et al. found that the presence of BMLs is
closely associated with high BMI and suggested that
obesity might be an important factor in their formation
[10]. Similarly, Felson et al. found that knee malalign-
ment and high loading of the joint associate with the
presence of BMLs [28]. In this study, we did not find a
significant relationship between BMI and the presence
of BMLs but we did not measure knee malalignment. It
is likely that knee loading is not simply a function of
BMI, but involves both the frequency and manner of
loading. By creating a distribution map of lesions in the
tibial plateau, we found that both types of BML are
Fig. 3 Comparison of cartilage volume (a), Osteoarthritis Research Society International; (OARSI) grades (b), cartilage tidemark progression (arrows
identify tidemarks) (c), penetration of vascular cones (circled) (d). Histopathology of bone marrow; bone marrow edema (e), fibrosis (f), necrosis
(g), thick-walled arterioles (h) and fibrovascular cystic formation (i). Represented histologically and graphically for specimens with no bone marrow
lesions evident (No BML), bone marrow lesions evident only in fast spin-echo proton density-weighted (PDFS) sequences (BML 1), and bone marrow
lesions evident in both PDFS and T1-weighted sequences (BML 2): *p = 0.05, **p = 0.005, ***p = 0.0005
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predominantly located in the medial compartment,
which is most commonly affected by degenerative
changes in knee OA. Furthermore, contours of the BML
distribution correspond to the contours of the tibial
areas with high contact pressure [41]. Several studies
have suggested that high repetitive joint loading can ini-
tiate a cellular response to bone injury and/or micro-
damage in terms of increased bone remodeling.
Increased remodeling is closely associated with thicken-
ing of the subchondral plate (endochondral ossification
evident as presence of multiple tidemark duplications)
and increased vascular invasion of the deep layers of ar-
ticular cartilage, which leads to loss of cartilage thickness
and integrity, and finally complete cartilage loss. Sub-
chondral bone in OA undergoes sclerotic changes, with
increased trabecular number and volume but with de-
creased mineralization [15, 42–44]. Although less studied,
the subchondral plate also shows thickening [45, 46],
which is believed to increase with progression of OA [19,
43, 47, 48]. The present study found each of those phe-
nomena to be highly represented within the tibial plateau
with BML 2, intermediate with BML 1 and minimal with
no BML, supporting a mechanical origin of BMLs.
Interestingly, BML 2 bone displayed increased osteoid
thickness in the subchondral plate and increased osteoid
volume in the trabeculae, compared to BML 1. This may
indicate a defect in osteoid mineralization, previously
linked with increased levels of transforming growth fac-
tor (TGF)-β in OA, which is reported to occur prior to
loss of cartilage [49]. A recent study by Zhen et al. in
mice suggests an important role of TGF-β1 in both sub-
chondral pathological change and cartilage degeneration
during the progression of OA [50]. Evidence was obtained
from transgenic animals over- or under-expressing TGF-
β1 to show that high concentrations of TGF-β1 in the
subchondral bone contribute to OA development and
progression. Similar to the present findings in human
OA BMLs, increased osteoid and vasculature were
Fig. 4 Micro-computed tomography bone analysis (a), subchondral plate, thickness and surface of closed pores; subchondral trabecular bone,
bone volume fraction and structural model index. Bone turnover in subchondral plate (b), osteoid volume over tissue volume, volume of osteoid,
osteoid surface over tissue volume and thickness of osteoid. Bone turnover in trabecular bone (c), osteoid volume over tissue volume, volume of
osteoid, erosion surface over bone surface and thickness of osteoid. Represented graphically for specimens with no bone marrow lesions evident
(No BML), bone marrow lesions evident only in fast spin-echo proton density-weighted (PDFS) sequences (BML 1), and bone marrow lesions
evident in both PDFS and T1-weighted sequences (BML 2): *p = 0.05, **p = 0.005, ***p = 0.0005. BV bone volume, TV tissue volume, OV osteoid vol-
ume, OS osteoid surface, O.Th osteoid thickness, ES erosion surface, BS bone surface
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consequences of TGF-β over-expression. The authors
suggested that the osteoid islets might correspond to
the BML signal detected by MRI [50]. Although this
is possible, we have not been able to unequivocally
assign the BML signals to any specific feature in the
subchondral bone.
Our data suggest that the use of specific MRI se-
quences offers potential application for OA disease sta-
ging and to identify individuals with more advanced
structural progression of disease. In particular, BML 2
appears to represent subchondral tissue and cartilage
with more degenerative structural changes and therefore
less ability to resolve or repair (Table 4). As we found
intermediate differences between BML 1 and BML 2, we
propose that BML 1 might be an early or transitional
stage of BML. In both human and animal studies it has
been found that BMLs in the early stage of disease are
dynamic and can resolve within time. Perhaps BMLs
seen only by PDFS MRI sequences are those that have
the ability to resolve [16, 51], making them a potential
target for early diagnosis and potential therapy. Further
studies of early-stage OA are needed to confirm this
possibility and to investigate modifiable risk factors for
the initiation of BMLs. The importance of BMLs as
therapeutic targets has been recognized, and there are
current studies in which BML size and frequency are
serving as an outcome measure [39, 52]. Therapies that
target BMLs as biomarkers of the initiation and/or pro-
gression of knee OA might be more effective than those
targeting cartilage repair, as cartilage degradation might be
a consequence of failed repair mechanisms in subchondral
bone and/or bone marrow. We therefore propose that
BML 1 may be a better candidate for targeted treatments
and as an outcome measure, than BML 2.
This study has several limitations. First, we have only
examined ex vivo tibial plateau samples from patients with
advanced and painful knee OA. However, this limitation
will be present for any human OA histopathological stud-
ies. It may be important that our recent clinical study
broadly supports our ex vivo findings, namely that BML 2
was associated with greater cartilage volume loss and
more incident pain [38]. Second, BMLs were identified
post-operatively and damage during handling could pos-
sibly have led to altered signal on the post-operative MRI.
We have taken care to minimize potential artifacts in
post-operative MRI by using the same handling protocol
for all specimens and by excluding the cut surfaces from
our analysis. Third, we only investigated BMLs from knee
OA and findings might differ for other skeletal joints. We
believe that the strength of this study is that we have
analyzed a large number of specimens compared to
previous studies, using a comprehensive multi-modal
analysis of changes in cartilage, bone and bone marrow
in association with BMLs. Fourth, the thickness of our
specimens was between 5 and 15 mm, and clinically
BMLs may be considerably larger than this and might
expand to a greater depth within the tibia. On the other
hand, it has been found that bone structural changes
are most prominent in the first 6 mm of depth beneath
the cartilage [42].
Conclusion
The presence of BMLs detected by specific MRI se-
quences is strongly associated with the degree of struc-
tural change in the OCU in knee OA. Furthermore,
different MRI sequences appear able to differentiate dif-
ferent degrees of structural damage in knee OA. There-
fore, BMLs detected with specific sequences could act as
potential MRI biomarkers for the identification of
individuals at high risk of progressive OA or for de-
velopment and monitoring of new therapies for this
condition.
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BV: bone volume; cl.pores: closed pores; ES: erosion surface; FS: fat suppressed;
H&E: hematoxylin and eosin; ICC: intraclass correlation coefficient; K&L: Kellgren
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Table 4 Group with no bone marrow lesions (No BML) vs.






MRI cartilage volume Not different Low
OARSI histology score High High
Bone marrow pathology
Edema Not different High
Fibrosis Not different High
Necrosis Not different High
Vascularity High High
Subchondral bone
Plate thickness High Very high
Trabecular bone volume Not different High
Osteoid volume and thickness Not different High
Changes at tissue level between the No BML group vs. group with BML
detected using the fast spin-echo proton density-weighted sequence only,
with absent signal on T1-weighted sequence in the same area (BML 1) and the
group with BML detected by both fast spin-echo proton density-weighted and
T1 sequences (BML 2). MRI magnetic resonance imaging, OARSI Osteoarthritis
Research Society International
Muratovic et al. Arthritis Research & Therapy  (2016) 18:54 Page 9 of 11
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors meet criteria for authorship. DM designed the study, performed
the experiments and analysis of the results, interpreted the data and wrote
the manuscript. FC, AW, DF and JK designed the study, interpreted the data,
provided overall supervision and wrote the manuscript. SO analyzed
histopathology, interpreted the data and critically revised the manuscript. DT
and YW analyzed, advised on interpretation of the MRI data and critically
revised the manuscript. JH and Y-RL contributed to collection of specimens
from patients, performed the experiments and critically revised the manuscript.
AL and RW contributed to development of methods and critically revised the
manuscript. All authors read and approved the manuscript.
Acknowledgements
The authors wish to thank Ms Sue Collins and Ms Emma Giersch for
technical assistance, Dr Graham Mercer, Dr Chris Wilson, and Dr Dai Morgan
for helping to obtain specimens. The authors wish to acknowledge the staff
support from Adelaide Microscopy, Anatomical Pathology at SA Pathology,
and Department of Radiology, Royal Adelaide Hospital. A National Health
and Medical Research Council of Australia (NHMRC) Project Grant (1042482)
and support from the Rebecca Cooper Foundation funded this work. DM is
the recipient of an NHMRC scholarship; AEW is the recipient of an NHMRC
Career Development Fellowship (Clinical level 2, 1063574).
Author details
1Discipline of Orthopaedics and Trauma, The University of Adelaide, Adelaide,
Australia. 2Bone and Joint Research Laboratory, SA Pathology, Frome Road,
Adelaide 5000, Australia. 3Department of Epidemiology & Preventive Medicine,
Monash University, Melbourne, Australia. 4Anatomical Pathology, SA Pathology,
Adelaide, Australia. 5Department of Radiology, Royal Adelaide Hospital,
Adelaide, Australia. 6Adelaide Microscopy, The University of Adelaide, Adelaide,
Australia.
Received: 2 December 2015 Accepted: 9 February 2016
References
1. Mahjoub M, Berenbaum F, Houard X. Why subchondral bone in
osteoarthritis? The importance of the cartilage bone interface in
osteoarthritis. Osteoporos Int. 2012;23 Suppl 8:S841–6.
2. Davies-Tuck ML, Wluka AE, Wang Y, English DR, Giles GG, Cicuttini F. The
natural history of bone marrow lesions in community-based adults with no
clinical knee osteoarthritis. Ann Rheum Dis. 2009;68(6):904–8.
3. Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM, et al.
The association of bone marrow lesions with pain in knee osteoarthritis.
Ann Intern Med. 2001;134(7):541–9.
4. Zhai G, Blizzard L, Srikanth V, Ding C, Cooley H, Cicuttini F, et al. Correlates
of knee pain in older adults: Tasmanian Older Adult Cohort Study. Arthritis
Rheum. 2006;55(2):264–71.
5. Roemer FW, Guermazi A, Javaid MK, Lynch JA, Niu J, Zhang Y, et al. Change
in MRI-detected subchondral bone marrow lesions is associated with
cartilage loss: the MOST Study. A longitudinal multicentre study of knee
osteoarthritis. Ann Rheum Dis. 2009;68(9):1461–5.
6. Hunter DJ, Zhang Y, Niu J, Goggins J, Amin S, LaValley MP, et al. Increase in
bone marrow lesions associated with cartilage loss: a longitudinal magnetic
resonance imaging study of knee osteoarthritis. Arthritis Rheum. 2006;54(5):
1529–35.
7. Wluka AE, Wang Y, Davies-Tuck M, English DR, Giles GG, Cicuttini FM. Bone
marrow lesions predict progression of cartilage defects and loss of cartilage
volume in healthy middle-aged adults without knee pain over 2 yrs.
Rheumatology (Oxford). 2008;47(9):1392–6.
8. Wluka AE, Hanna F, Davies-Tuck M, Wang Y, Bell RJ, Davis SR, et al. Bone
marrow lesions predict increase in knee cartilage defects and loss of
cartilage volume in middle-aged women without knee pain over 2 years.
Ann Rheum Dis. 2009;68(6):850–5.
9. Zubler V, Mengiardi B, Pfirrmann CW, Duc SR, Schmid MR, Hodler J, et al.
Bone marrow changes on STIR MR images of asymptomatic feet and ankles.
Eur Radiol. 2007;17(12):3066–72.
10. Guymer E, Baranyay F, Wluka AE, Hanna F, Bell RJ, Davis SR, et al. A study of the
prevalence and associations of subchondral bone marrow lesions in the knees
of healthy, middle-aged women. Osteoarthritis Cartilage. 2007;15(12):1437–42.
11. Baranyay FJ, Wang Y, Wluka AE, English DR, Giles GG, Sullivan RO, et al.
Association of bone marrow lesions with knee structures and risk factors for
bone marrow lesions in the knees of clinically healthy, community-based
adults. Semin Arthritis Rheum. 2007;37(2):112–8.
12. Sowers MF, Hayes C, Jamadar D, Capul D, Lachance L, Jannausch M, et al.
Magnetic resonance-detected subchondral bone marrow and cartilage
defect characteristics associated with pain and X-ray-defined knee
osteoarthritis. Osteoarthritis Cartilage. 2003;11(6):387–93.
13. Roemer FW, Neogi T, Nevitt MC, Felson DT, Zhu Y, Zhang Y, et al.
Subchondral bone marrow lesions are highly associated with, and predict
subchondral bone attrition longitudinally: the MOST study. Osteoarthritis
Cartilage. 2010;18(1):47–53.
14. Link TM, Steinbach LS, Ghosh S, Ries M, Lu Y, Lane N, et al. Osteoarthritis:
MR imaging findings in different stages of disease and correlation with
clinical findings. Radiology. 2003;226(2):373–81.
15. Kamibayashi L, Wyss UP, Cooke TD, Zee B. Trabecular microstructure in the
medial condyle of the proximal tibia of patients with knee osteoarthritis.
Bone. 1995;17(1):27–35.
16. Berry PA, Davies-Tuck ML, Wluka AE, Hanna FS, Bell RJ, Davis SR, et al. The
natural history of bone marrow lesions in community-based middle-aged
women without clinical knee osteoarthritis. Semin Arthritis Rheum. 2009;
39(3):213–7.
17. Zanetti M, Bruder E, Romero J, Hodler J. Bone marrow edema pattern in
osteoarthritic knees: correlation between MR imaging and histologic
findings. Radiology. 2000;215(3):835–40.
18. Taljanovic MS, Graham AR, Benjamin JB, Gmitro AF, Krupinski EA, Schwartz
SA, et al. Bone marrow edema pattern in advanced hip osteoarthritis:
quantitative assessment with magnetic resonance imaging and correlation
with clinical examination, radiographic findings, and histopathology. Skeletal
Radiol. 2008;37(5):423–31.
19. Hunter DJ, Gerstenfeld L, Bishop G, Davis AD, Mason ZD, Einhorn TA, et al.
Bone marrow lesions from osteoarthritis knees are characterized by sclerotic
bone that is less well mineralized. Arthritis Res Ther. 2009;11(1):R11.
20. Martig S, Boisclair J, Konar M, Spreng D, Lang J. MRI characteristics and
histology of bone marrow lesions in dogs with experimentally induced
osteoarthritis. Vet Radiol Ultrasound. 2007;48(2):105–12.
21. Loeuille D, Chary-valckenaere I. MRI in OA: from cartilage to bone marrow
lesion. Osteoporos Int. 2012;23(8):867–9.
22. Roemer FW, Khrad H, Hayashi D, Jara H, Ozonoff A, Fotinos-Hoyer AK, et al.
Volumetric and semiquantitative assessment of MRI-detected subchondral
bone marrow lesions in knee osteoarthritis: a comparison of contrast-enhanced
and non-enhanced imaging. Osteoarthritis Cartilage. 2010;18(8):1062–6.
23. Raynauld JP, Martel-Pelletier J, Berthiaume MJ, Abram F, Choquette D,
Haraoui B, et al. Correlation between bone lesion changes and cartilage
volume loss in patients with osteoarthritis of the knee as assessed by
quantitative magnetic resonance imaging over a 24-month period. Ann
Rheum Dis. 2008;67(5):683–8.
24. Carrino JA, Blum J, Parellada JA, Schweitzer ME, Morrison WB. MRI of bone
marrow edema-like signal in the pathogenesis of subchondral cysts.
Osteoarthritis Cartilage. 2006;14(10):1081–5.
25. Dore D, Martens A, Quinn S, Ding C, Winzenberg T, Zhai G, et al. Bone
marrow lesions predict site-specific cartilage defect development and
volume loss: a prospective study in older adults. Arthritis Res Ther. 2010;
12(6):R222.
26. Driban JB, Tassinari A, Lo GH, Price LL, Schneider E, Lynch JA, et al. Bone
marrow lesions are associated with altered trabecular morphometry.
Osteoarthritis Cartilage. 2012;20(12):1519–26.
27. Hayashi D, Guermazi A, Kwoh CK, Hannon MJ, Moore C, Jakicic JM, et al.
Semiquantitative assessment of subchondral bone marrow edema-like
lesions and subchondral cysts of the knee at 3T MRI: a comparison between
intermediate-weighted fat-suppressed spin echo and Dual Echo Steady
State sequences. BMC Musculoskelet Disord. 2011;12:198.
28. Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, et
al. Bone marrow edema and its relation to progression of knee
osteoarthritis. Ann Intern Med. 2003;139(5 Pt 1):330–6.
29. Kijowski R, Stanton P, Fine J, De Smet A. Subchondral bone marrow edema
in patients with degeneration of the articular cartilage of the knee joint.
Radiology. 2006;238(3):943–9.
Muratovic et al. Arthritis Research & Therapy  (2016) 18:54 Page 10 of 11
30. Lowitz T, Museyko O, Bousson V, Laouisset L, Kalender WA, Laredo JD, et al.
Bone marrow lesions identified by MRI in knee osteoarthritis are associated
with locally increased bone mineral density measured by QCT. Osteoarthritis
Cartilage. 2013;21(7):957–64.
31. Laslett LL, Dore DA, Quinn SJ, Boon P, Ryan E, Winzenberg TM, et al.
Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a
randomised controlled trial. Ann Rheum Dis. 2012;71(8):1322–8.
32. Kleemann RU, Krocker D, Cedraro A, Tuischer J, Duda GN. Altered cartilage
mechanics and histology in knee osteoarthritis: relation to clinical
assessment (ICRS Grade). Osteoarthritis Cartilage. 2005;13(11):958–63.
33. Zanetti M, Steiner CL, Seifert B, Hodler J. Clinical outcome of edema-like
bone marrow abnormalities of the foot. Radiology. 2002;222(1):184–8.
34. Kazakia GJ, Kuo D, Schooler J, Siddiqui S, Shanbhag S, Bernstein G, et al.
Bone and cartilage demonstrate changes localized to bone marrow edema-like
lesions within osteoarthritic knees. Osteoarthritis Cartilage. 2013;21(1):94–101.
35. Driban JB, Lo GH, Lee JY, Ward RJ, Miller E, Pang J, et al. Quantitative bone
marrow lesion size in osteoarthritic knees correlates with cartilage damage
and predicts longitudinal cartilage loss. BMC Musculoskelet Disord.
2011;12:217.
36. Pritzker KPH, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, et al.
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr
Cartil. 2006;14(1):13–29.
37. Pauli C, Whiteside R, Heras FL, Nesic D, Koziol J, Grogan SP, et al.
Comparison of cartilage histopathology assessment systems on human
knee joints at all stages of osteoarthritis development. Osteoarthritis
Cartilage. 2012;20(6):476–85.
38. Wluka ATA, Maulana R, Liu B, Wang Y, Giles G, O’Sullivan R, et al. Bone
Marrow Lesions can be subtyped into groups with different clinical
outcomes using 2 Magnetic Resonance imaging (MRI) sequences. Arthr Res
Ther. 2015;17:270. doi:10.1186/s13075-015-0780-5.
39. Roemer FW, Kwoh CK, Hannon MJ, Hunter DJ, Eckstein F, Fujii T, et al. What
comes first? Multitissue involvement leading to radiographic osteoarthritis:
magnetic resonance imaging-based trajectory analysis over four years in the
Osteoarthritis Initiative. Arthritis Rheumatol. 2015;67(8):2085–96.
40. Saadat E, Jobke B, Chu B, Lu Y, Cheng J, Li X, et al. Diagnostic performance
of in vivo 3-T MRI for articular cartilage abnormalities in human
osteoarthritic knees using histology as standard of reference. Eur Radiol.
2008;18(10):2292–302.
41. Donahue TL, Hull ML, Rashid MM, Jacobs CR. A finite element model of the
human knee joint for the study of tibio-femoral contact. J Biomech Eng.
2002;124(3):273–80.
42. Patel V, Issever AS, Burghardt A, Laib A, Ries M, Majumdar S. MicroCT
evaluation of normal and osteoarthritic bone structure in human knee
specimens. J Orthop Res. 2003;21(1):6–13.
43. Bobinac D, Spanjol J, Zoricic S, Maric I. Changes in articular cartilage and
subchondral bone histomorphometry in osteoarthritic knee joints in
humans. Bone. 2003;32(3):284–90.
44. Messent EA, Ward RJ, Tonkin CJ, Buckland-Wright C. Tibial cancellous bone
changes in patients with knee osteoarthritis. A short-term longitudinal study
using Fractal Signature Analysis. Osteoarthritis Cartilage. 2005;13(6):463–70.
45. Burr DB, Radin EL. Microfractures and microcracks in subchondral bone: are
they relevant to osteoarthrosis? Rheum Dis Clin N Am. 2003;29(4):675–85.
46. Burr DB. Anatomy and physiology of the mineralized tissues: role in the
pathogenesis of osteoarthrosis. Osteoarthritis Cartilage. 2004;12 Suppl A:
S20–30.
47. Milz S, Putz R. Quantitative morphology of the subchondral plate of the
tibial plateau. J Anat. 1994;185(Pt 1):103–10.
48. Sharma AR, Jagga S, Lee SS, Nam JS. Interplay between cartilage and
subchondral bone contributing to pathogenesis of osteoarthritis. Int J Mol
Sci. 2013;14(10):19805–30.
49. Crane JL, Cao X. Bone marrow mesenchymal stem cells and TGF-beta
signaling in bone remodeling. J Clin Invest. 2014;124(2):466–72.
50. Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, et al. Inhibition of TGF-beta
signaling in mesenchymal stem cells of subchondral bone attenuates
osteoarthritis. Nat Med. 2013;19(6):704–12.
51. Davies-Tuck ML, Hanna F, Davis SR, Bell RJ, Davison SL, Wluka AE, et al. Total
cholesterol and triglycerides are associated with the development of new
bone marrow lesions in asymptomatic middle-aged women - a prospective
cohort study. Arthritis Res Ther. 2009;11(6):R181.
52. Driban JB, Price L, Lo GH, Pang J, Hunter DJ, Miller E, et al. Evaluation of
bone marrow lesion volume as a knee osteoarthritis biomarker–longitudinal
relationships with pain and structural changes: data from the Osteoarthritis
Initiative. Arthritis Res Ther. 2013;15(5):R112.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Muratovic et al. Arthritis Research & Therapy  (2016) 18:54 Page 11 of 11
